The Cancer Stem Cells and the Quiescence

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: 31 May 2025 | Viewed by 73

Special Issue Editor


E-Mail Website
Guest Editor
Departments of Genetics, Cell Biology & Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: stem cells (mammary stem cells, intestinal stem cells); cancer stem cells; breast cancer research; breast pathology; animal modeling; preclinical targeting; organoid systems; ovarian cancer research

Special Issue Information

Dear Colleagues,

Mounting evidence links cancer stem cells (CSCs) to tumor initiation, maintenance, resistance to therapy, recurrence and metastasis. CSCs are a small self-renewing population, associated with quiescent or dormant states rather than cycling, which makes them drug-resistant or refractory to treatment. Further, they initiate metastasis at distal organs, known to account for 90% of cancer-related mortality. To initiate metastasis at distant organs, CSCs can remain dormant for days to years. Upon receiving appropriate signaling cues, CSCs then give rise to metastasis. CSCs have been implicated as drug persisters, drug-tolerant populations, and dormant cells of tumors. There are also reports that propose that the dormancy and quiescence of CSCs exist as two different entities. Therefore, understanding the regulators of quiescence and/or dormancy of CSCs is an unmet goal to develop therapeutic strategies targeting therapy-resistant, metastatic, and recurrent cancers. Further experimental findings warrant better understanding of these two processes. To study CSC biology, it is essential to identify, isolate and propagate CSCs in in vitro and in vivo settings. The in vitro 3D culture of CSCs provides the opportunities to maintain a tumor-like state ex vivo, study tumor biology, and screen drugs and inhibitors. We would like to invite research and review papers on the broad field of cancer stem cells not limited to quiescence. This Special Issue of Cancers covers all aspects of CSCs, including the identification of novel markers of quiescent CSCs, animal models to understand CSC biology, metastasis, cell signaling, dormancy, metabolism, and preclinical and clinical studies of therapy developments. Expert opinions and systematic reviews are also welcome.

We look forward to receiving your contributions.

Dr. Bhopal Mohapatra
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer stem cells
  • new markers
  • organoid cultures
  • cancer cell dormancy and quiescence
  • metastasis
  • animal models
  • metabolism
  • drug resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop